No Detail Found!

Luteinizing hormone to follicle stimulating hormone ratio in patients with polycystic ovary syndrome

Author(s)
Madiha Khattak Department of Physiology, Khyber Medical College,Peshawar, Pakistan
Nuzhat Sultana Department of Pathology, Northwest School of Medicine,Peshawar, Pakistan
Robina Usman Department of Physiology, Peshawar Medical College, Peshawar-Pakistan
Umama Khattak Department of Physiology, Khyber Medical College,Peshawar, Pakistan
Umema Zafar Department of Physiology, Khyber Medical College,Peshawar, Pakistan
Henna Salman Department of Physiology, Khyber Medical College,Peshawar, Pakistan
Abstract
Background: Polycystic ovary syndrome is the most commonly occurring endocrinopathy in females of reproductive age group. It is characterized by a wide range of signs and symptoms resulting from hormonal derangements leading to reduced fertility. Methods: This was a crosssectional (comparative) study. We took 40 cases of polycystic ovary syndrome and 40 controls of infertility without polycystic ovary syndrome depending on the presence of clinical features and ultrasound scans. Blood samples were collected and assayed for luteinizing hormone and follicle stimulating hormone. Data was analyzed with SPSS-19. Results: Luteinizing hormone to follicle stimulating hormone ratio was raised in 3 out of 35 patients (8%) in cases and in 2 out of 39 patients (5%) in controls. There was no statistically significant difference in the luteinizing hormone levels and the follicle stimulating hormone levels and the luteinizing hormone to follicle stimulating hormone ratio of the two groups as indicated by a p-value> 0.05. Conclusion: Luteinizing hormone to follicle stimulating hormone ratio was not found to be raised in majority of the polycystic ovary syndrome patients included in this study.
Publication Details
Page(s) 255-258
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 32, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Luteinizing hormone, Infertility, follicle stimulating hormone, Polycystic ovary syndrome
0

Citations

0

Downloads

52

Views